High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention
- 1 August 2003
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (4) , 17-22
- https://doi.org/10.1016/s0002-9149(03)00774-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular EventsCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Inflammation and AtherosclerosisCirculation, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged MenCirculation, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997